GetTopicDetailResponse(id=aac931312ad, topicName=凝血, introduction=凝血, content=null, image=null, comments=2, allHits=2090, url=https://h5.medsci.cn/topic?id=31312, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=9998, tagList=[TagDto(tagId=9998, tagName=凝血)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2193470, encodeId=1cf621934e069, content=<a href='/topic/show?id=a5ae23159d2' target=_blank style='color:#2F92EE;'>#主動(dòng)脈夾層#</a> <a href='/topic/show?id=aac931312ad' target=_blank style='color:#2F92EE;'>#凝血#</a>, objectTitle=系統(tǒng)凝血-炎癥指數(shù)（SCI）預(yù)測(cè)急性A型主動(dòng)脈夾層手術(shù)預(yù)后, objectType=article, longId=817224, objectId=f89d81e224f1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301012/1697150253256_4754896.jpeg, objectUrl=/article/show_article.do?id=f89d81e224f1, replyNumber=0, likeNumber=106, createdTime=2024-03-15, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f89d81e224f1, moduleTitle=系統(tǒng)凝血-炎癥指數(shù)（SCI）預(yù)測(cè)急性A型主動(dòng)脈夾層手術(shù)預(yù)后, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f89d81e224f1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2187973, encodeId=1c82218e9730f, content=<a href='/topic/show?id=aac931312ad' target=_blank style='color:#2F92EE;'>#凝血#</a> <a href='/topic/show?id=1504148222f' target=_blank style='color:#2F92EE;'>#PT#</a>, objectTitle=患者PT延長(zhǎng)竟和ICU這類常用藥藥有關(guān)？！, objectType=article, longId=810920, objectId=83ff81092043, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/patient-meeting-a-doctor-PAYSRMZ.jpg, objectUrl=/article/show_article.do?id=83ff81092043, replyNumber=0, likeNumber=112, createdTime=2024-02-18, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=83ff81092043, moduleTitle=患者PT延長(zhǎng)竟和ICU這類常用藥藥有關(guān)？！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=83ff81092043)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2164392, encodeId=5d4a216439257, content=<a href='/topic/show?id=9dbd3059eeb' target=_blank style='color:#2F92EE;'>#內(nèi)鏡黏膜下剝離術(shù)#</a>(ESD)是為了提高內(nèi)鏡黏膜切除術(shù)(EMR)切除大于2 cm病灶的能力，但與<a href='/topic/show?id=ac106e33e1' target=_blank style='color:#2F92EE;'>#EMR#</a>相比需要額外的技術(shù)技巧、延長(zhǎng)手術(shù)時(shí)間、增加出血和穿孔等不良事件的發(fā)生率。遲發(fā)性出血是<a href='/topic/show?id=7770e00507' target=_blank style='color:#2F92EE;'>#ESD#</a>術(shù)后最常見的并發(fā)癥，發(fā)生率為4.1% ~ 11.8%。雖然預(yù)防性對(duì)人工潰瘍的基底血管進(jìn)行<a href='/topic/show?id=aac931312ad' target=_blank style='color:#2F92EE;'>#凝血#</a>(ESD后凝血)和<a href='/topic/show?id=02f99235e23' target=_blank style='color:#2F92EE;'>#質(zhì)子泵抑制劑#</a>(PPI)是胃ESD術(shù)后常規(guī)使用的方法，以最大限度地減少延遲性出血的風(fēng)險(xiǎn)，但據(jù)報(bào)道，即使使用這些方法，出血率仍為3-5.5%。, objectTitle=Digestive Endoscopy：抽吸凝血方法降低胃內(nèi)鏡黏膜下剝離術(shù)后遲發(fā)性出血的風(fēng)險(xiǎn), objectType=article, longId=797316, objectId=00f3e97316fd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696895568746_4754896.jpeg, objectUrl=/article/show_article.do?id=00f3e97316fd, replyNumber=0, likeNumber=127, createdTime=2023-10-23, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=00f3e97316fd, moduleTitle=Digestive Endoscopy：抽吸凝血方法降低胃內(nèi)鏡黏膜下剝離術(shù)后遲發(fā)性出血的風(fēng)險(xiǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=00f3e97316fd)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=892090, encodeId=747c892090e8, content=<a href='/topic/show?id=aac931312ad' target=_blank style='color:#2F92EE;'>#凝血#</a>無凝血障礙患者腰椎穿刺術(shù)后發(fā)生脊髓血腫的風(fēng)險(xiǎn)為0.20%，有凝血障礙的患者為0.23%，男性及年齡是影響穿刺后脊髓血腫的重要因素。, objectTitle=JAMA：凝血障礙與腰椎穿刺術(shù)后脊髓血腫風(fēng)險(xiǎn), objectType=article, longId=202120, objectId=adeb20212087, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201014/1602674762466_2051781.jpg, objectUrl=/article/show_article.do?id=adeb20212087, replyNumber=0, likeNumber=169, createdTime=2020-10-14, rootId=0, userName=神盾醫(yī)療局局長(zhǎng)Jack, userId=ab235268530, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adeb20212087, moduleTitle=JAMA：凝血障礙與腰椎穿刺術(shù)后脊髓血腫風(fēng)險(xiǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=adeb20212087)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
前往app查看評(píng)論內(nèi)容
#內(nèi)鏡黏膜下剝離術(shù)#(ESD)是為了提高內(nèi)鏡黏膜切除術(shù)(EMR)切除大于2 cm病灶的能力，但與#EMR#相比需要額外的技術(shù)技巧、延長(zhǎng)手術(shù)時(shí)間、增加出血和穿孔等不良事件的發(fā)生率。遲發(fā)性出血是#ESD#術(shù)后最常見的并發(fā)癥，發(fā)生率為4.1% ~ 11.8%。雖然預(yù)防性對(duì)人工潰瘍的基底血管進(jìn)行#凝血#(ESD后凝血)和#質(zhì)子泵抑制劑#(PPI)是胃ESD術(shù)后常規(guī)使用的方法，以最大限度地減少延遲性出血的風(fēng)險(xiǎn)，但據(jù)報(bào)道，即使使用這些方法，出血率仍為3-5.5%。
